Cite
Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
MLA
Park, Jung Hwa, et al. “Isolinderalactone Suppresses Human Glioblastoma Growth and Angiogenic Activity in 3D Microfluidic Chip and in Vivo Mouse Models.” Cancer Letters, vol. 478, May 2020, pp. 71–81. EBSCOhost, https://doi.org/10.1016/j.canlet.2020.03.009.
APA
Park, J. H., Kim, M. J., Kim, W. J., Kwon, K.-D., Ha, K.-T., Choi, B. T., Lee, S.-Y., & Shin, H. K. (2020). Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models. Cancer Letters, 478, 71–81. https://doi.org/10.1016/j.canlet.2020.03.009
Chicago
Park, Jung Hwa, Min Jae Kim, Woo Jean Kim, Ki-Dong Kwon, Ki-Tae Ha, Byung Tae Choi, Seo-Yeon Lee, and Hwa Kyoung Shin. 2020. “Isolinderalactone Suppresses Human Glioblastoma Growth and Angiogenic Activity in 3D Microfluidic Chip and in Vivo Mouse Models.” Cancer Letters 478 (May): 71–81. doi:10.1016/j.canlet.2020.03.009.